(MENAFN- GlobeNewsWire - Nasdaq) The global Vitamin K2 market is projected to grow from USD 179.0 million in 2026 to USD 339.9 million by 2031, registering a 13.7% CAGR. Growth is driven by rising demand for bone and cardiovascular health supplements, preventive healthcare, functional nutrition, and clean-label ingredients. MK-7 is expected to dominate due to its high bioavailability, while pharmaceuticals offer significant growth potential. Asia Pacific will be the fastest-growing region, supported by aging populations and e-commerce expansion. Key players include Gnosis by Lesaffre, Balchem, J-OIL MILLS, Novonesis, and Vesta Nutra.Dublin, Oct. 01, 2026 (GLOBE NEWSWIRE) -- "Vitamin K2 Market by Application, Product Type, Application Form, Source, Function, and Region - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering.
The global Vitamin K2 market is projected to grow from USD 179.0 million in 2026 to USD 339.9 million by 2031, registering a compound annual growth rate of 13.7% during the forecast period. Market expansion is being supported by rising consumer awareness of bone and cardiovascular health, greater demand for preventive healthcare, and increased adoption of dietary supplements and functional nutrition products.
Consumers' growing focus on long-term wellness is increasing demand for Vitamin K2 ingredients associated with calcium metabolism, bone mineralization, and cardiovascular health. Scientifically validated, clean-label, and naturally derived ingredients are gaining particular attention, encouraging the use of fermentation-based Vitamin K2 in dietary supplements, functional foods and beverages, and pharmaceutical applications.
Additional growth factors include an expanding aging population, increasing incidence of osteoporosis and cardiovascular disorders, and higher healthcare expenditure across developed and emerging economies. Demand is also benefiting from the incorporation of Vitamin K2 into personalized nutrition solutions and other functional health products.
Product innovation and processing technologies support market expansion
Vitamin K2 manufacturers are investing in product innovation and advanced production technologies to improve ingredient purity, stability, and bioavailability. Development activity is concentrated on high-quality MK-7 and MK-4 formulations produced through natural fermentation, chemical synthesis, and biotechnological fermentation.
Advances in purification processes, microencapsulation technologies, and formulation solutions are improving stability and expanding the use of Vitamin K2 across capsules and tablets, powders and crystalline products, and liquid formats. Scientific research, clinical trials, and expanding regulatory approvals are also creating opportunities for suppliers and product developers.
Market growth may be moderated by stringent and inconsistent regulatory requirements, limited consumer awareness in developing regions, raw material and production costs, and intensifying competition among manufacturers. These factors make regulatory expertise, validated claims, manufacturing efficiency, and product differentiation increasingly important to market participants.
MK-7 expected to remain the dominant Vitamin K2 product segment
By product type, MK-7 is projected to lead the Vitamin K2 market. Vitamin K2 MK-7 products, including MenaQ7 and vitaMK7, have gained market recognition for bone and cardiovascular health applications. Their bioavailability, extended half-life, and role in activating osteocalcin and Matrix Gla Protein support their use in formulations focused on skeletal integrity, calcium utilization, and cardiovascular health.
Demand for MK-7 is expected to increase as consumers seek scientifically supported supplements and manufacturers expand targeted health offerings for diverse demographic groups. Persistent dietary deficiencies and greater awareness of preventive nutrition further strengthen the commercial outlook for MK-7 products.
Pharmaceutical applications forecast to record significant growth
The pharmaceuticals segment is projected to achieve significant growth during the forecast period as research continues to evaluate Vitamin K2 across multiple health applications. However, pharmaceutical use remains subject to stringent regional regulatory frameworks.
Primary interviews with Vitamin K2 manufacturers indicate that pharmaceutical applications are currently concentrated in Asia Pacific. Although several countries in the region manufacture pharmaceutical-grade Vitamin K2, consumption is primarily observed in China and Japan. Government insights, ongoing research, and clinical trials continue to support the ingredient's potential in pharmaceutical formulations.
Asia Pacific positioned as the fastest-growing regional market
Asia Pacific is projected to be the fastest-growing region in the global Vitamin K2 market. Growth is being driven by demographic, economic, and lifestyle trends, including rapidly aging populations in Japan, China, and South Korea. The increasing prevalence of osteoporosis, cardiovascular conditions, and other age-related health concerns is strengthening demand for nutritional products addressing bone and cardiovascular health.
The rapid expansion of e-commerce across Asia Pacific is also improving access to Vitamin K2 supplements. Amazon, Alibaba, and regional online retail platforms have increased product visibility and enabled broader distribution, including to consumers in remote locations. This expanding digital retail infrastructure is expected to support both established brands and new market entrants.
Competitive landscape and leading Vitamin K2 companies
Prominent companies operating in the Vitamin K2 market include Gnosis by Lesaffre of France, Balchem Corporation of the US, J-OIL MILLS, INC. of Japan, Novonesis A/S of Denmark, Guangdong Sungen Bioscience Co., Ltd. of China, and Vesta Nutra of the US.
The competitive assessment also covers Shandong Richen Nutritional Technology Co., Ltd. of China; Menadiona S.L. of Spain; GF Fermentech Co., Ltd. of South Korea; Angel Yeast Co., Ltd. of China; GeneFerm Biotechnology Co., Ltd. of Taiwan; Nakoda Chemicals Ltd. of India; Haihang Industry Co., Ltd. of China; Chemicea Limited of India; and Kyowa Hakko U.S.A., Inc. of the US.
The analysis examines market shares, growth strategies, product portfolios, brand and product comparisons, geographic footprints, contracts, partnerships, agreements, product and service launches, mergers and acquisitions, investments, and recent industry developments. It also evaluates emerging startups across the Vitamin K2 market ecosystem.
Research methodology and market segmentation
In-depth interviews were conducted with chief executive officers, directors, managers, and other executives from key organizations active in the Vitamin K2 industry. By company type, respondents comprised 30% Tier 1 companies, 25% Tier 2 companies, and 45% Tier 3 companies. By designation, the interview base included 25% CXOs, 35% managers, and 40% other executives.
The Vitamin K2 market research is segmented by product type into MK-4 and MK-7. Application forms include capsules and tablets, powder and crystalline formats, and liquids. Source categories comprise natural and synthetic Vitamin K2, while applications include pharmaceuticals, functional foods and beverages, and health supplements.
Market functions covered in the report include bone and cardiovascular health, blood health and clotting, anti-inflammatory and immunity applications, and other functions. Processing technologies include natural fermentation, chemical synthesis, biotechnological fermentation, and other production methods. Regional coverage comprises North America, Europe, Asia Pacific, and the Rest of the World.
Strategic insights for Vitamin K2 market stakeholders
The report evaluates major market drivers, restraints, opportunities, and challenges. Key factors include rising health consciousness, inconsistent regulatory norms, growing demand for natural and plant-based ingredients, and limited consumer awareness of the specific health benefits associated with Vitamin K2.
Product development and innovation: Analysis of research and development activity, processing advances, formulation improvements, and new Vitamin K2 product launches. Market development: Assessment of high-growth opportunities and regional demand across established and emerging markets. Market diversification: Information on new ingredient sources, untapped geographies, investments, and recent market developments. Technology and regulation: Coverage of technology trends, ecosystem and market mapping, patents, clinical research, and the regulatory landscape. Competitive assessment: Evaluation of leading companies, emerging participants, market positioning, product offerings, and growth strategies.
The research provides market leaders and new entrants with revenue estimates for the overall Vitamin K2 market and its subsegments. It is designed to help stakeholders evaluate the competitive environment, identify growth opportunities, strengthen market positioning, and develop effective go-to-market strategies through 2031.
Key Attributes:
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment